LENZ Therapeutics’ (LENZ) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of LENZ Therapeutics (NASDAQ:LENZ – Free Report) in a report published on Thursday morning,Benzinga reports. They currently have a $38.00 price objective on the stock. HC Wainwright also issued estimates for LENZ Therapeutics’ FY2029 earnings at $1.52 EPS. Other research analysts have also issued reports about the […]
HC Wainwright reaffirmed their buy rating on shares of LENZ Therapeutics (NASDAQ:LENZ – Free Report) in a report published on Thursday morning,Benzinga reports. They currently have a $38.00 price objective on the stock. HC Wainwright also issued estimates for LENZ Therapeutics’ FY2029 earnings at $1.52 EPS. Other research analysts have also issued reports about the […]
